Journal
Journal of Heart and Lung Transplantation
Publication Date
2-1-2024
Volume
43
Issue
2
First Page
272
Last Page
283
Document Type
Open Access Publication
DOI
10.1016/j.healun.2023.09.016
Rights and Permissions
McLaughlin V, Farber HW, Highland KB, Hemnes AR, Chakinala MM, Chin KM, Han M, Cho M, Tobore T, Rahman M, Kim NH. Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry). J Heart Lung Transplant. 2024 Feb;43(2):272-283. doi: 10.1016/j.healun.2023.09.016. © 2023 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
McLaughlin, Vallerie; Farber, Harrison W; Highland, Kristin B; Hemnes, Anna R; Chakinala, Murali M; Chin, Kelly M; Han, Michelle; Cho, Michelle; Tobore, Tobore; Rahman, Mohammad; and Kim, Nick H, "Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)." Journal of Heart and Lung Transplantation. 43, 2. 272 - 283. (2024).
https://digitalcommons.wustl.edu/oa_4/3529
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
